Senior Scientist, Analytical Development
CurrentFormerly APP PharmaceuticalsDeveloped or improved analytical procedures using HPLC, GC, AA, ICP-OES, and circular dichroism (CD) for the analysis of pharmaceutical drug products and raw materials. Wrote and executed or oversaw execution of protocols for analytical method validation or verification of HPLC, GC, AA, and CD methods, and provided final report to management. Evaluated potential raw material suppliers by reviewing their technical documentation and testing samples for comparison to provide recommendations to management regarding feasibility of new projects under consideration. Provided miscellaneous analytical support such as reference standard qualification, release testing, and testing samples for formulation development.Completed Trackwise Power User training and gained experience in OOS investigations.Pioneered the use of Minitab and Fusion QbD LC Method Development within the department to conduct robustness studies using Quality by Design principles and responsible for updating department procedures to incorporate use of modelling software and elements of multivariate design of experiments and risk assessments to guide method robustness studies.Analytical techniques, in addition to those listed below: GC and GC-MS, AA, CCIT (differential pressure), circular dichroism, ATR-FTIR